Global Patent Index - EP 1596845 A1

EP 1596845 A1 20051123 - THERAPEUTIC USE OF ACYL GLYCEROLS AND THE NITROGEN- AND SULPHUR-CONTAINING ANALOGUES THEROF

Title (en)

THERAPEUTIC USE OF ACYL GLYCEROLS AND THE NITROGEN- AND SULPHUR-CONTAINING ANALOGUES THEROF

Title (de)

THERAPEUTISCHE VERWENDUNG VON ACYLIERTEN GLYCEROLDERIVATEN UND DEREN STICKSTOFF- UND SCHWEFELANALOGEN

Title (fr)

UTILISATION THERAPEUTIQUE DE GLYCEROLS ACYLES ET DE LEURS ANALOGUES AZOTES ET SULFURES

Publication

EP 1596845 A1 20051123 (FR)

Application

EP 04710415 A 20040212

Priority

  • FR 2004000322 W 20040212
  • FR 0301691 A 20030212

Abstract (en)

[origin: FR2850870A1] The use of acylated glycerols, and their nitrogen and sulfur analogs (I), their optical and geometric isomers, racemates, salts, hydrates, and mixtures, for the prevention and treatment of neurodegenerative disorders. The use of acylated glycerols, and their nitrogen and sulfur analogs (I), their optical and geometric isomers, racemates, salts, hydrates, and mixtures, for the prevention and treatment of neurodegenerative disorders. [Image] G1O or N-R; G2, G3O, S, N-R4, with the proviso that G1, G2, and G3 may not simultaneously represent N-R or N-R4; R, R4H or optionally substituted, optionally unsaturated 1-5C alkyl; R1, R2, R3H, CO-R5, CO-(CH2)2n+1-X-R6, with the proviso that at least one is CO-(CH2)2n+1-X-R6; R5optionally substituted, optionally unsaturated, optionally cyclic alkyl having 1-25 C atoms in the main chain; R6optionally substituted, optionally unsaturated, optionally cyclic alkyl having 3-23 C atoms in the main chain and optionally containing one or more hetero groups selected from O, S, Se, SO and SO2; X : S, Se, SO, or SO2; n : 0-11. ACTIVITY : Antiparkinsonian; Nootropic; Neuroprotective. MECHANISM OF ACTION : Alpha Peroxisome Proliferator-Activated Receptor (PPARalpha ) Agonist.

IPC 1-7

A61K 31/045; A61K 31/22; A61K 31/25; A61K 31/265; A61P 25/28

IPC 8 full level

A61K 31/045 (2006.01); A61K 31/22 (2006.01); A61K 31/25 (2006.01); A61K 31/265 (2006.01); A61P 25/28 (2006.01)

CPC (source: EP US)

A61K 31/045 (2013.01 - EP US); A61K 31/22 (2013.01 - EP US); A61K 31/25 (2013.01 - EP US); A61K 31/265 (2013.01 - EP US); A61P 25/28 (2017.12 - EP)

Citation (search report)

See references of WO 2004073698A1

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

Designated extension state (EPC)

AL LT LV MK

DOCDB simple family (publication)

FR 2850870 A1 20040813; FR 2850870 B1 20060728; EP 1596845 A1 20051123; US 2006154984 A1 20060713; WO 2004073698 A1 20040902

DOCDB simple family (application)

FR 0301691 A 20030212; EP 04710415 A 20040212; FR 2004000322 W 20040212; US 54251205 A 20050718